AI
| Followers | 3163 |
| Posts | 209639 |
| Boards Moderated | 1 |
| Alias Born | 02/04/2004 |
Tuesday, October 10, 2017 8:21:09 PM
I'll be the 1st to admit that I'm mistaken if anyone can prove to me and/or show me where I'm wrong...but for me the Bloomberg reported PAR/FocalinXR sales for IPCI's fiscal Q2 and fiscal Q3 periods don't even remotely match up to the actual revenue numbers IPCI has now reported for both reporting periods.
Enough from me tonight...see ya's all tomorrow...and here's angelo's spreadsheet that prove the posted Bloomberg numbers for PAR/FocalinXR sales March through August...which were IPCI's fiscal Q2 and Q3>>>
Enough from me tonight...see ya's all tomorrow...and here's angelo's spreadsheet that prove the posted Bloomberg numbers for PAR/FocalinXR sales March through August...which were IPCI's fiscal Q2 and Q3>>>
Never buy or sell based on my posts! My posts are just my opinion!
